| European Case Law Identifier: | ECLI:EP:BA:1997:T018793.19970305 | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Date of decision: | 05 March 1997 | ||||||||
| Case number: | T 0187/93 | ||||||||
| Application number: | 84305909.8 | ||||||||
| IPC class: | A61K 39/245 | ||||||||
| Language of proceedings: | EN | ||||||||
| Distribution: | B | ||||||||
| Download and more information: |
|
||||||||
| Title of application: | Vaccines based on membrane bound proteins and process for making them | ||||||||
| Applicant name: | GENENTECH, INC. | ||||||||
| Opponent name: | Chiron Corporation | ||||||||
| Board: | 3.3.04 | ||||||||
| Headnote: | - | ||||||||
| Relevant legal provisions: |
|
||||||||
| Keywords: | Main, first and second auxiliary requests - sufficiency of disclosure and support by the description (no) Third auxiliary request - added matter (yes) Fourth auxiliary request - sufficiency of disclosure - support by the description (yes) Novelty (yes) Inventive step (yes) no reasonable expectation of success |
||||||||
| Catchwords: |
If a given technical effect (here: immunoprotection in vivo) is solely relied upon in order to demonstrate that a claimed subject-matter (here: a vaccine against a viral pathogen and its production method) involves an inventive step, claims of a broad scope are not allowable under Articles 83 and 84 EPC when, on the basis of the disclosure in the European patent application or the European patent and of the common general knowledge at the date of filing or at the priority date, said technical effect cannot be achieved by the skilled person without undue burden within the whole range of application claimed (cf. points 2 to 7 of the Reasons). |
||||||||
| Cited decisions: |
|
||||||||
| Citing decisions: |
|
||||||||
Source: http://www.epo.org/law-practice/case-law-appeals/recent/t930187eu1.html
Date retrieved: 17 May 2021